The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
Open accessAbstract
Despite improvements in awareness and treatment of type II diabetes mellitus (TIIDM), this disease remains a major source of morbidity and mortality worldwide, and prevalence continues to rise. Oxidative damage caused by free radicals has long been known to contribute to the pathogenesis and progression of TIIDM and its complications. Only recently, however, has the role of the Nrf2/Keap1/ARE master antioxidant pathway in diabetic dysfunction begun to be elucidated. There is accumulating evidence that this pathway is implicated in diabetic damage to the pancreas, heart, and skin, among other cell types and tissues. Animal studies and clinical trials have shown promising results suggesting that activation of this pathway can delay or reverse some of these impairments in TIIDM. In this review, we outline the role of oxidative damage and the Nrf2/Keap1/ARE pathway in TIIDM, focusing on current and future efforts to utilize this relationship as a therapeutic target for prevention, prognosis, and treatment of TIID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bhakkiyalakshmi, E., Shalini, D., Sekar, T. V., Rajaguru, P., Paulmurugan, R., & Ramkumar, K. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12577 · Cited by 113
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Decades of scientific research, randomized human trials, and clinical experience have demonstrated that a combination of lifestyle modifications and pharmaceutical interventions has the capacity to prevent or delay the onset of TIIDM and many of its devastating complications [6].”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700 · cited 1×
“The absolute risk of cardiovascular disease (CVD) is 2-fold greater in patients with TIIDM versus those without, and at least 65% of people with DM die of heart disease or stroke [3, 62].”
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Furthermore, obesity is associated with an increased risk of developing insulin resistance and TIIDM, and murine studies have likewise shown that Nrf2 induction can suppress weight gain and increase skeletal muscle oxygen consumption, mitochondrial redox homeostasis, and ATP production, as well as augment cellular glu…”
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 1×
“First isolated in cloning studies in 1994 [22], the critical role of Nrf2, a member of the cap’n’collar family of basic leucine zipper transcription factors, in both constitutive and inducible ARE gene expression was soon elucidated both in vitro [23] and in vivo [20, 21, 24].”
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491 · cited 1×
“Pancreatic β-cell dysfunction and the resulting impairments in insulin sensitivity and production are a critical component in the development and progression of both type I and type II DM [36], and oxidative stress is one important mechanism whereby this damage occurs [37].”
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“It is nonetheless understood that modification of cysteine residues in the primary structure of Keap1, which act as cellular sensors for inducers of environmental stress, by thiol-reactive chemical species during states of excess oxidative or electrophilic stress results in the disruption of the Nrf2-Keap1 dimer and s…”
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 1×
“For instance, Nrf2 regulates blood glucose homeostasis and metabolic reprogramming by redirecting anabolic pathways [175], inhibiting lipogenesis [176], and promoting insulin sensitization, thereby ameliorating insulin resistance [177].”
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,381
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192666 · Cited by 1,359
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., Yang, M., Raghupathi, K., Novas, M., Sweetser, M. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206328 · Cited by 1,355
Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene
Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M. K., & Cook, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26071 · Cited by 1,285
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
(1979) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60848-9 · Cited by 1,163
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141 · cited 2×
“Keap1 is a cytoplasmic, actin cytoskeleton-associated adapter protein of the Cullin3(Cul3-) based E3-ligase complex, which tags Nrf2 for ubiquitination and subsequent proteosomal degradation within the cytoplasm [21].”
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,141
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
US spending on personal health care and public health, 1996-2013.
Dieleman, J. L., Baral, R., Birger, M., Bui, A. L., Bulchis, A., Chapin, A., Hamavid, H., Horst, C., Johnson, E. K., Joseph, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16885 · Cited by 1,044
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Clinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E. L., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 909
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 790
Oxidative damage to DNA in diabetes mellitus
Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., & Nicotera, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90013-6 · Cited by 787
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., & Hori, M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2398 · Cited by 712
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017) · Population Health Management · doi:10.1089/pop.2015.0181 · Cited by 655
LAU, A., VILLENEUVE, N., SUN, Z., WONG, P., & ZHANG, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.003 · Cited by 645
Curcumin Extract for Prevention of Type 2 Diabetes
Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., & Jirawatnotai, S. (2012) · Diabetes Care · doi:10.2337/dc12-0116 · Cited by 635
Zweier, J. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57309-4 · Cited by 634
Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 629
Trends in cardiovascular complications of diabetes
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.292.20.2495 · Cited by 626
Zweier, J. L., Kuppusamy, P., & Lutty, G. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4046 · Cited by 602
The Nrf2–ARE Pathway: An Indicator and Modulator of Oxidative Stress in Neurodegeneration
Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., & Chen, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.036 · Cited by 589
Insulin Resistance and Risk of Congestive Heart Failure
Ingelsson, E., Sundström, J., Ärnlöv, J., Zethelius, B., & Lind, L. (2005) · JAMA · doi:10.1001/jama.294.3.334 · Cited by 573
Direct and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
Oxidative stress, anti‐oxidant therapies and chronic kidney disease
SMALL, D. M., COOMBES, J. S., BENNETT, N., JOHNSON, D. W., & GOBE, G. C. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01572.x · Cited by 514
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production
Waltner-Law, M. E., Wang, X. L., Law, B. K., Hall, R. K., Nawano, M., & Granner, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204672200 · Cited by 487
Cinnamaldehyde--a potential antidiabetic agent
Subash Babu, P., Prabuseenivasan, S., & Ignacimuthu, S. (2007) · Phytomedicine · doi:10.1016/j.phymed.2006.11.005 · Cited by 477
Kim, H. J., & Vaziri, N. D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00421.2009 · Cited by 474
Abnormal angiogenesis in diabetes mellitus
Martin, A., Komada, M. R., & Sane, D. C. (2003) · Medicinal Research Reviews · doi:10.1002/med.10024 · Cited by 455
Holmström, K. M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J. M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A. T., & Abramov, A. Y. (2013) · Biology Open · doi:10.1242/bio.20134853 · Cited by 448
Oxidative Stress and Hypertension
Harrison, D. G., & Gongora, M. C. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.015 · Cited by 445
Chesley, A., Lundberg, M. S., Asai, T., Xiao, R.-P., Ohtani, S., Lakatta, E. G., & Crow, M. T. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1172 · Cited by 422
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
Mercuri, F., Tonutti, L., Taboga, C., Ceriello, A., Assaloni, R., Motz, E., & Quagliaro, L. (2001) · Diabetologia · doi:10.1007/s001250100529 · Cited by 419
Tan, Y., Ichikawa, T., Li, J., Si, Q., Yang, H., Chen, X., Goldblatt, C. S., Meyer, C. J., Li, X., Cai, L., et al. (2011) · Diabetes · doi:10.2337/db10-1164 · Cited by 392
Palsamy, P., & Subramanian, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.008 · Cited by 380
Lonn, E., Yusuf, S., Hoogwerf, B., Pogue, J., Yi, Q., Zinman, B., Bosch, J., Dagenais, G., Mann, J. F. E., Gerstein, H. C., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.1919 · Cited by 364
Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion
Leloup, C., Tourrel-Cuzin, C., Magnan, C., Karaca, M., Castel, J., Carneiro, L., Colombani, A.-L., Ktorza, A., Casteilla, L., & Pénicaud, L. (2009) · Diabetes · doi:10.2337/db07-1056 · Cited by 361 · cited 1×
“While some studies show that ROS impairs insulin release through mechanisms such as a reduction in ATP production [48] and increased glyceraldehyde 3-phosphate dehydrogenase (GAPDH) activity [49], there is a growing body of evidence indicating that oxidative and electrophilic stress can actually augment, and may even…”
Sussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804333106 · Cited by 346
Lee, J.-H., Song, M.-Y., Song, E.-K., Kim, E.-K., Moon, W. S., Han, M.-K., Park, J.-W., Kwon, K.-B., & Park, B.-H. (2009) · Diabetes · doi:10.2337/db07-1795 · Cited by 346
Nguyen, T., Sherratt, P. J., Nioi, P., Yang, C. S., & Pickett, C. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503074200 · Cited by 344
Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells
Chen, X.-L., Varner, S. E., Rao, A. S., Grey, J. Y., Thomas, S., Cook, C. K., Wasserman, M. A., Medford, R. M., Jaiswal, A. K., & Kunsch, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203161200 · Cited by 333
Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents
Wolfram, S., Raederstorff, D., Preller, M., Wang, Y., Teixeira, S. R., Riegger, C., & Weber, P. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.10.2512 · Cited by 331
Shapiro, T. A., Fahey, J. W., Dinkova-Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., & Talalay, P. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_7 · Cited by 330
Oxidative stress and cardiovascular disease: Novel tools give (free) radical insight
Fearon, I. M., & Faux, S. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.05.013 · Cited by 328
The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T. W., & Yamamoto, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00225-13 · Cited by 328
Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells
Sakai, K., Matsumoto, K., Nishikawa, T., Suefuji, M., Nakamaru, K., Hirashima, Y., Kawashima, J., Shirotani, T., Ichinose, K., Brownlee, M., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02832-2 · Cited by 324
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
Cornblatt, B. S., Ye, L., Dinkova-Kostova, A. T., Erb, M., Fahey, J. W., Singh, N. K., Chen, M.-S. A., Stierer, T., Garrett-Mayer, E., Argani, P., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm049 · Cited by 320
Seo, K., Choi, M., Jung, U. J., Kim, H., Yeo, J., Jeon, S., & Lee, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700184 · Cited by 313
Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
Ashrafian, H., Czibik, G., Bellahcene, M., Aksentijević, D., Smith, A. C., Mitchell, S. J., Dodd, M. S., Kirwan, J., Byrne, J. J., Ludwig, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.017 · Cited by 302
Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300
Pi, J., Leung, L., Xue, P., Wang, W., Hou, Y., Liu, D., Yehuda-Shnaidman, E., Lee, C., Lau, J., Kurtz, T. W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093955 · Cited by 298
Williams, B., Gallacher, B., Patel, H., & Orme, C. (1997) · Diabetes · doi:10.2337/diab.46.9.1497 · Cited by 295
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Aleksunes, L. M., & Manautou, J. E. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311344 · Cited by 285
Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice
Wruck, C. J., Fragoulis, A., Gurzynski, A., Brandenburg, L.-O., Kan, Y. W., Chan, K., Hassenpflug, J., Freitag-Wolf, S., Varoga, D., Lippross, S., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132720 · Cited by 283
Shin, S., Wakabayashi, J., Yates, M. S., Wakabayashi, N., Dolan, P. M., Aja, S., Liby, K. T., Sporn, M. B., Yamamoto, M., & Kensler, T. W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.022 · Cited by 275
Bai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C., Chen, Q., Tan, Y., Cui, T., Zheng, Y., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.008 · Cited by 274
An Essential Role of NRF2 in Diabetic Wound Healing
Long, M., Rojo de la Vega, M., Wen, Q., Bharara, M., Jiang, T., Zhang, R., Zhou, S., Wong, P. K., Wondrak, G. T., Zheng, H., et al. (2016) · Diabetes · doi:10.2337/db15-0564 · Cited by 265
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Movahed, A., Nabipour, I., Lieben Louis, X., Thandapilly, S. J., Yu, L., Kalantarhormozi, M., Rekabpour, S. J., & Netticadan, T. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/851267 · Cited by 257
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Li, J., Ichikawa, T., Villacorta, L., Janicki, J. S., Brower, G. L., Yamamoto, M., & Cui, T. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.189480 · Cited by 253
Oxidative stress and frailty: A systematic review and synthesis of the best evidence
Soysal, P., Isik, A. T., Carvalho, A. F., Fernandes, B. S., Solmi, M., Schofield, P., Veronese, N., & Stubbs, B. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.01.006 · Cited by 252
Targeting the pancreatic β-cell to treat diabetes
Vetere, A., Choudhary, A., Burns, S. M., & Wagner, B. K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4231 · Cited by 252
Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
Zakkar, M., Van der Heiden, K., Luong, L. A., Chaudhury, H., Cuhlmann, S., Hamdulay, S. S., Krams, R., Edirisinghe, I., Rahman, I., Carlsen, H., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.193375 · Cited by 247
Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
McGuinness, A., & Sapey, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020021 · Cited by 243
Sabri, A., Hughie, H. H., & Lucchesi, P. A. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770380034 · Cited by 236
The Keap1-Nrf2 system and diabetes mellitus
Uruno, A., Yagishita, Y., & Yamamoto, M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.012 · Cited by 231
Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., Dinkova-Kostova, A. T., Dillon, J. F., Hayes, J. D., & Ashford, M. L. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00677-14 · Cited by 229
Hosoya, T., Maruyama, A., Kang, M.-I., Kawatani, Y., Shibata, T., Uchida, K., Itoh, K., & Yamamoto, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502551200 · Cited by 227
NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
Boutten, A., Goven, D., Artaud-Macari, E., Boczkowski, J., & Bonay, M. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.006 · Cited by 221
Zhong, Q., Mishra, M., & Kowluru, R. A. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11598 · Cited by 221
Advanced glycoxidation products and impaired diabetic wound healing
Peppa, M., Stavroulakis, P., & Raptis, S. A. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00518.x · Cited by 216
Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A., Takeuchi, M., Yamagishi, S., Morito, N., Nakano, T., Ojima, M., Shimohata, H., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01234.x · Cited by 207
Sahin, K., Tuzcu, M., Gencoglu, H., Dogukan, A., Timurkan, M., Sahin, N., Aslan, A., & Kucuk, O. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.06.014 · Cited by 206
Nrf2 Protects Pancreatic β-Cells From Oxidative and Nitrosative Stress in Diabetic Model Mice
Yagishita, Y., Fukutomi, T., Sugawara, A., Kawamura, H., Takahashi, T., Pi, J., Uruno, A., & Yamamoto, M. (2014) · Diabetes · doi:10.2337/db13-0909 · Cited by 204
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
Harmon, J. S., Bogdani, M., Parazzoli, S. D., Mak, S. S. M., Oseid, E. A., Berghmans, M., LeBoeuf, R. C., & Robertson, R. P. (2009) · Endocrinology · doi:10.1210/en.2009-0708 · Cited by 182
Sussan, T. E., Jun, J., Thimmulappa, R., Bedja, D., Antero, M., Gabrielson, K. L., Polotsky, V. Y., & Biswal, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003791 · Cited by 179
Nrf2–keap1 system versus NF-κB: The good and the evil in chronic kidney disease?
Pedruzzi, L. M., Stockler-Pinto, M. B., Leite, M., & Mafra, D. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.015 · Cited by 173
Yu, Z., Shao, W., Chiang, Y., Foltz, W., Zhang, Z., Ling, W., Fantus, I. G., & Jin, T. (2011) · Diabetologia · doi:10.1007/s00125-010-2001-8 · Cited by 173
Song, M.-Y., Kim, E.-K., Moon, W.-S., Park, J.-W., Kim, H.-J., So, H.-S., Park, R., Kwon, K.-B., & Park, B.-H. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.007 · Cited by 169
Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea.
Bolli, R., Zhu, W. X., Hartley, C. J., Michael, L. H., Repine, J. E., Hess, M. L., Kukreja, R. C., & Roberts, R. (1987) · Circulation · doi:10.1161/01.cir.76.2.458 · Cited by 167
Ungvari, Z., Bailey-Downs, L., Gautam, T., Jimenez, R., Losonczy, G., Zhang, C., Ballabh, P., Recchia, F. A., Wilkerson, D. C., Sonntag, W. E., et al. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00402.2010 · Cited by 162
Jyrkkänen, H.-K., Kansanen, E., Inkala, M., Kivelä, A. M., Hurttila, H., Heinonen, S. E., Goldsteins, G., Jauhiainen, S., Tiainen, S., Makkonen, H., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.176883 · Cited by 160
Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing
Rabbani, P. S., Zhou, A., Borab, Z. M., Frezzo, J. A., Srivastava, N., More, H. T., Rifkin, W. J., David, J. A., Berens, S. J., Chen, R., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.001 · Cited by 158
Self-citationThe emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
Bhakkiyalakshmi, E., Sireesh, D., Rajaguru, P., Paulmurugan, R., & Ramkumar, K. M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.004 · Cited by 156
Kubisch, H. M., Wang, J., Bray, T. Μ., & Phillips, J. P. (1997) · Diabetes · doi:10.2337/diabetes.46.10.1563 · Cited by 154
Rajasekaran, N. S., Varadharaj, S., Khanderao, G. D., Davidson, C. J., Kannan, S., Firpo, M. A., Zweier, J. L., & Benjamin, I. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3587 · Cited by 148
Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo
Hu, C.-M., Chen, Y., Chiang, M., & Chau, L. (2004) · Circulation · doi:10.1161/01.cir.0000135475.35758.23 · Cited by 140
Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L., Peng, Y., Dong, X., Huang, H., Si, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075927 · Cited by 138
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats
Abe, T., Ohga, Y., Tabayashi, N., Kobayashi, S., Sakata, S., Misawa, H., Tsuji, T., Kohzuki, H., Suga, H., Taniguchi, S., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h138 · Cited by 136
Oxidative stress and hypertension
Harrison, D. G., Góngora, M. C., Guzik, T. J., & Widder, J. D. (2007) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2006.11.006 · Cited by 136
The Double-Edged Sword of Nrf2: Subversion of Redox Homeostasis during the Evolution of Cancer
Hayes, J. D., & McMahon, M. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.004 · Cited by 134
Nrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress
Yagishita, Y., Uruno, A., Fukutomi, T., Saito, R., Saigusa, D., Pi, J., Fukamizu, A., Sugiyama, F., Takahashi, S., & Yamamoto, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.064 · Cited by 134
Song, E. K., Hur, H., & Han, M. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976881 · Cited by 128
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety
Fox, R. J., Kita, M., Cohan, S. L., Henson, L. J., Zambrano, J., Scannevin, R. H., O'Gorman, J., Novas, M., Dawson, K. T., & Phillips, J. T. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.849236 · Cited by 124 · cited 1×
“Of note, Nrf2 activators have already made their way into clinical practice; in 2013, dimethyl fumarate (BG-12, brand name Tecfidera®) was approved by the FDA for the treatment of multiple sclerosis and is thought to exert its therapeutic effects via augmentation of Nrf2’s downstream cytoprotective, anti-inflammatory,…”
Hyperglycemia-Induced Reactive Oxygen Species and Impaired Endothelial Progenitor Cell Function
Callaghan, M. J., Ceradini, D. J., & Gurtner, G. C. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1476 · Cited by 123
Self-citationHan, M. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.19 · Cited by 120
O’Brien, J. A., Patrick, A. R., & Caro, J. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80122-4 · Cited by 120
Lu, Z., Xu, X., Hu, X., Zhu, G., Zhang, P., van Deel, E. D., French, J. P., Fassett, J., Oury, T. D., Bache, R. J., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098186 · Cited by 119
Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching
Wei, Y., Gong, J., Thimmulappa, R. K., Kośmider, B., Biswal, S. S., & Duh, E. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309276110 · Cited by 117
Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang, Y., & Munday, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0625 · Cited by 114
The absence of macrophage Nrf2 promotes early atherogenesis
Ruotsalainen, A.-K., Inkala, M., Partanen, M. E., Lappalainen, J. P., Kansanen, E., Mäkinen, P. I., Heinonen, S. E., Laitinen, H. M., Heikkilä, J., Vatanen, T., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt008 · Cited by 109
Saha, P., Reddy, V. T., Konopleva, M. Y., Andreeff, M., & Chan, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176545 · Cited by 108
Matsushima, S., Kinugawa, S., Ide, T., Matsusaka, H., Inoue, N., Ohta, Y., Yokota, T., Sunagawa, K., & Tsutsui, H. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00427.2006 · Cited by 108
Aleksunes, L. M., Reisman, S. A., Yeager, R. L., Goedken, M. J., & Klaassen, C. D. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162271 · Cited by 106
Nrf2 and Redox Status in Prediabetic and Diabetic Patients
Jiménez‐Osorio, A. S., Picazo, A., González-Reyes, S., Barrera‐Oviedo, D., Rodríguez-Arellano, M. E., & Pedraza‐Chaverrí, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120290 · Cited by 105
Cinnamaldehyde protects from the hypertension associated with diabetes
El‐Bassossy, H. M., Fahmy, A., & Badawy, D. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.07.060 · Cited by 103
Ichikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008391 · Cited by 99 · cited 1×
“A number of studies utilizing pharmacologic Nrf2 activators have implicated the antioxidant properties of the Nrf2/Keap1/ARE pathway in cardioprotection [100, 101].”
Berȩsewicz, A., & Horackova, M. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)90133-7 · Cited by 99
Reactive oxygen species and excitation–contraction coupling in the context of cardiac pathology
Köhler, A. C., Sag, C. M., & Maier, L. S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.001 · Cited by 99
Zhu, H., Jia, Z., Zhang, L., Yamamoto, M. P., Misra, H. P., Trush, M. A., & Li, Y. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-rm-304 · Cited by 98
Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet
Zhang, Y.-K. J., Wu, K. C., Liu, J., & Klaassen, C. D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.09.014 · Cited by 97
Dysregulation of the Keap1–Nrf2 pathway in cancer
Leinonen, H. M., Kansanen, E., Pölönen, P., Heinäniemi, M., & Levonen, A. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150048 · Cited by 97
Pedruzzi, L. M., Cardozo, L., Daleprane, J. B., Stockler‐Pinto, M. B., Monteiro, E. B., Leite, M., Vaziri, N. D., & Mafra, D. (2015) · Journal of Nephrology · doi:10.1007/s40620-014-0162-0 · Cited by 95
Bitar, M. S., & Al‐Mulla, F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00047.2011 · Cited by 91
Restoration of Nrf2 Signaling Normalizes the Regenerative Niche
Soares, M. A., Cohen, O. D., Low, Y. C., Sartor, R. A., Ellison, T., Anil, U., Anzai, L. M., Chang, J. B., Saadeh, P. B., Rabbani, P. S., et al. (2015) · Diabetes · doi:10.2337/db15-0453 · Cited by 82
Self-citationCui, W., Li, B., Bai, Y., Miao, X., Chen, Q., Sun, W., Tan, Y., Luo, P., Zhang, C., Zheng, S., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2012 · Cited by 73
Saadeh, M., Ferrante, T. C., Kane, A., Shirihai, O. S., Corkey, B. E., & Deeney, J. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030200 · Cited by 72
Delayed Treatment with Lithospermate B Attenuates Experimental Diabetic Renal Injury
Lee, G. T., Ha, H., Jung, M., Li, H., Hong, S. W., Soo, B., Lee, H. C., & Cho, A. Y. D. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051660.82593.19 · Cited by 69
Lee, S., Hur, E.-G., Ryoo, I.-G., Jung, K.-A., Kwak, J., & Kwak, M. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.021 · Cited by 67
Nrf2 induces fibroblast growth factor 21 in diabetic mice
Furusawa, Y., Uruno, A., Yagishita, Y., Higashi, C., & Yamamoto, M. P. (2014) · Genes to Cells · doi:10.1111/gtc.12186 · Cited by 65
The status of Nrf2-based therapeutics: current perspectives and future prospects
Gazaryan, I. G., & Thomas, B. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.194706 · Cited by 64
Hur, K. Y., Kim, S. H., Choi, M.-A., Williams, D. R., Lee, Y., Kang, S. W., Yadav, U. C. S., Sk, S., Jung, M., Cho, J. W., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.035 · Cited by 62
Serdar, M. A., Sertoğlu, E., Uyanık, M., Tapan, S., Akın, K. O., Bilgi, C., & Kurt, İ. (2012) · Free Radical Research · doi:10.3109/10715762.2012.710902 · Cited by 61
Xing, Y., Niu, T., Wang, W., Li, J., Li, S., Janicki, J. S., Ruiz, S., Meyer, C. J., Wang, X. L., Tang, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044899 · Cited by 61
Early molecular events in the development of the diabetic cardiomyopathy
Moenkemann, H., Vriese, A. S. D., Blom, H. J., Kluijtmans, L. A. J., Heil, S. G., Schild, H. H., & Golubnitschaja, O. (2002) · Amino Acids · doi:10.1007/s00726-001-0146-y · Cited by 58
Chin, M. P., Lee, C.-Y. I., Chuang, J.-C., Bumeister, R., Wigley, W. C., Sonis, S. T., Ward, K. W., & Meyer, C. J. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00387.2012 · Cited by 58
Meher, A. K., Sharma, P. R., Lira, V. A., Yamamoto, M. P., Kensler, T. W., Yan, Z., & Leitinger, N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.022 · Cited by 55
Yu, Z., Li, D., Ling, W.-H., & Jin, T. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.19 · Cited by 48
Protective effect of gallic acid on alloxan-induced oxidative stress and osmotic fragility in rats
Ramkumar, K. M., Vijayakumar, R., Vanitha, P., Suganya, N., Manjula, C., Rajaguru, P., Sivasubramanian, S., & Gunasekaran, P. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113504792 · Cited by 47
Jiménez‐Osorio, A. S., González-Reyes, S., García‐Niño, W. R., Moreno-Macías, H., Rodríguez-Arellano, M. E., Vargas‐Alarcón, G., Zúñiga, J., Barquera, R., & Pedraza‐Chaverrí, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7367641 · Cited by 47
Jiang, B., Guo, L. C., Li, B., Zhen, J., Song, J., Peng, T., Yang, X., Hu, Z., & Gao, H. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2686 · Cited by 43
Chen, T.-M., Li, J., Liu, L., Li, F., Li, X.-Y., Wang, Y., Abraham, N. G., & Cao, J. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022684 · Cited by 40
Wu, K. C., McDonald, P. R., Liu, J. J., Chaguturu, R., & Klaassen, C. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044686 · Cited by 40
Sasaki, M., Fujimoto, S., Sato, Y., Nishi, Y., Mukai, E., Yamano, G., Sato, H., Tahara, Y., Ogura, K., Nagashima, K., et al. (2013) · Diabetes · doi:10.2337/db12-0903 · Cited by 40
Li, W., Wu, W., Song, H., Wang, F., Li, H., Chen, L., Lai, Y., Janicki, J. S., Ward, K. W., Meyer, C. J., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.046 · Cited by 36
Heme Oxygenase as an Intrinsic Defense System in Vascular Wall : Implication against Atherogenesis
Ishikawa, K., & Maruyama, Y. (2001) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.8.63 · Cited by 31
Song, J., Sumiyoshi, S., Nakashima, Y., Doi, Y., Iida, M., Kiyohara, Y., & Sueishi, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.057 · Cited by 30
Abbasi, A., Corpeleijn, E., Gansevoort, R. T., Gans, R. O. B., Struck, J., Schulte, J., Hillege, H. L., van der Harst, P., Stolk, R. P., Navis, G., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3278-9 · Cited by 27
Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
Tsai, W., Hueng, D., Lin, C.-R., Yang, T. C. ‐., & Gao, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050722 · Cited by 26
Fujimoto, S., Mukai, E., & Inagaki, N. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2011.07.013 · Cited by 23
Diabetic Wound Healing and Activation of Nrf2 by Herbal Medicine.
Senger, D. R., & Cao, S. (2016) · PubMed · Cited by 19
Early induction of NRF2 antioxidant pathway by RHBDF2 mediates rapid cutaneous wound healing
Hosur, V., Burzenski, L. M., Stearns, T. M., Farley, M. L., Sundberg, J. P., Wiles, M. V., & Shultz, L. D. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.03.003 · Cited by 15
Ashraf, J. M., Arfat, M. Y., Arif, Z., Ahmad, J., Moinuddin, M., & Alam, K. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2014.12.007 · Cited by 11
Li, J., Chen, T.-M., Cao, J., Chen, D.-Y., Wang, H., Shi, H., Gao, M., Fan, L., & Abraham, N. G. (2014) · PubMed · Cited by 1
Cited by
The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing
Deng, L., Du, C., Song, P., Chen, T., Rui, S., Armstrong, D. G., & Deng, W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8852759 · Cited by 763
Cano Sanchez, M., Lancel, S., Boulanger, E., & Neviere, R. (2018) · Antioxidants · doi:10.3390/antiox7080098 · Cited by 574
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress
Dludla, P. V., Mabhida, S. E., Ziqubu, K., Nkambule, B. B., Mazibuko-Mbeje, S. E., Hanser, S., Basson, A. K., Pheiffer, C., & Kengne, A. P. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i3.130 · Cited by 344
Metadata
- Authors
- David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J.
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-15
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2748095317
- Cited by
- 301
- References
- 179
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.